Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
about
Combinatorial approaches to the prevention and treatment of HIV-1 infectionGuidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theIntracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics.Emerging anti-HIV drugs.HIV recombination: what is the impact on antiretroviral therapy?Current status of antiretroviral therapy.Evolving simplified treatment strategies for HIV infection: the role of a single-class quadruple-nucleoside/nucleotide regimen of trizivir and tenofovir.Diagnostic and management challenges for childhood tuberculosis in the era of HIV.Pharmacotherapy of pediatric and adolescent HIV infectionPoor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal.Pediatric antiretroviral therapy.Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinic.Acute onset of pancreatitis with concomitant use of tenofovir and didanosine.Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France.Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS study.Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot study.
P2860
Q30400060-8AB8795F-62BE-4BED-9F38-D0582E314365Q34212799-25897AB5-BD93-4C28-8889-38777D8B3485Q34737466-7B04620F-04CB-47AA-957C-6782A083D85BQ36081993-C1D09709-E250-444B-981E-5CE08D98563DQ36150601-24062807-72B7-4A89-9F74-C46DA0B42D75Q36539852-DA27BE68-D30E-4486-A252-FF4874D477E6Q36548703-7928E84A-5FD3-4854-8FE8-A52C10B2882DQ36632238-B020F549-B1BC-47C8-80AB-01C7E10D28C2Q36877242-EB573423-E31D-4A3E-8DF6-6CD9DE9B2FF8Q37240305-909666F0-0AD8-45E6-9127-A6A8C60B32E6Q37379962-D0864BDE-389B-4EC5-A0CA-FB67B595AE8BQ37816389-0B539CBC-03DD-4307-99C2-8AF7AE0D147CQ43421983-21515E4A-8C6F-4CE0-9C3B-E8FDBCB7C699Q43857998-0A48FE2A-8637-48FA-965C-7F4B646E8484Q45060352-30812CC0-A2DE-4D92-8B01-AE97E17B42F6Q46200243-6FC721D0-973F-4B46-8F1E-5D6C772AC36EQ46923092-7BC71DBE-8CFD-4237-ABFB-22185DED0E84Q46923098-855294B2-C0E6-4E50-91C7-A3FA62FCEE3FQ47404336-2974EE8B-A8C2-4A98-B27D-79C8CC6FDC0EQ51481656-06FC840D-77CE-4683-A287-A83D419D9BBB
P2860
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Low efficacy and high frequenc ...... vir, stavudine and didanosine.
@en
Low efficacy and high frequenc ...... vir, stavudine and didanosine.
@nl
type
label
Low efficacy and high frequenc ...... vir, stavudine and didanosine.
@en
Low efficacy and high frequenc ...... vir, stavudine and didanosine.
@nl
prefLabel
Low efficacy and high frequenc ...... vir, stavudine and didanosine.
@en
Low efficacy and high frequenc ...... vir, stavudine and didanosine.
@nl
P2093
P50
P1433
P1476
Low efficacy and high frequenc ...... vir, stavudine and didanosine.
@en
P2093
Court Pedersen
Henrik Nielsen
Jan Gerstoft
Lars Mathiesen
P304
P356
10.1097/00002030-200309260-00005
P407
P577
2003-09-01T00:00:00Z